华海药业(600521) - 2016 Q1 - 季度财报

Financial Performance - Operating revenue rose by 32.50% to CNY 968,008,230.26 year-on-year[7] - Net profit attributable to shareholders increased by 21.37% to CNY 121,791,096.58[7] - Basic and diluted earnings per share rose by 15.38% to CNY 0.15[7] - Total operating revenue for the current period reached ¥968,008,230.26, a 32.5% increase from ¥730,548,293.83 in the previous period[26] - Net profit for the current period was ¥121,204,812.69, representing a 21.0% increase compared to ¥100,163,668.00 in the previous period[26] - The company reported a total profit of ¥136,967,656.30, an increase of 15.4% from ¥118,725,895.43 in the previous period[26] Cash Flow - Net cash flow from operating activities improved significantly, with a reduction in outflow of 89.35% to -CNY 5,027,531.64[7] - Cash flow from operating activities showed a net outflow of ¥5,027,531.64, an improvement from a net outflow of ¥47,222,796.22 in the previous period[32] - Operating cash flow for Q1 2016 was CNY 91,100,778.74, a significant improvement compared to a negative cash flow of CNY -20,284,416.70 in the same period last year[35] - The total cash inflow from operating activities was CNY 603,091,161.28, compared to CNY 539,060,430.83 in the previous year, indicating a positive trend in operational efficiency[35] Assets and Liabilities - Total assets increased by 6.63% to CNY 5,881,049,678.97 compared to the end of the previous year[7] - Current liabilities rose to ¥1,914,448,301.10, up from ¥1,682,476,746.02, indicating an increase of about 13.8%[20] - Total liabilities increased to ¥2,026,255,355.76 from ¥1,795,142,089.28, reflecting a growth of approximately 12.9%[20] - Owner's equity reached ¥3,854,794,323.21, compared to ¥3,720,353,656.62, marking an increase of about 3.6%[20] - Non-current assets totaled ¥2,887,483,533.04, up from ¥2,719,902,259.57, reflecting an increase of about 6.2%[23] Shareholder Information - The total number of shareholders reached 18,869 at the end of the reporting period[11] - The largest shareholder, Chen Baohua, holds 26.76% of the shares, with 134,100,000 shares pledged[11] Expenses - Total operating costs increased to ¥830,119,710.63, up 34.2% from ¥618,594,541.83 in the previous period[26] - Sales expenses increased to ¥102,403,755.61, a rise of 42.0% from ¥72,253,310.03 in the previous period[26] - Management expenses rose to ¥184,375,312.95, up 51.7% from ¥121,519,999.86 in the previous period[26] - Financial expenses skyrocketed by 513.04% to ¥11,793,362.90, attributed to increased interest expenses and foreign exchange losses[14] Government Subsidies and Non-Operating Income - The company received government subsidies amounting to CNY 1,753,619.60 related to normal business operations[8] - The company reported a 69.51% decline in non-operating income to ¥1,827,579.20, primarily due to a reduction in government subsidies received[14] - Non-operating income and expenses resulted in a net loss of CNY 483,033.86 for the period[9] Inventory and Current Assets - Inventory decreased to ¥1,049,733,867.17 from ¥1,077,348,035.61, indicating a reduction in stock levels[18] - Other current assets surged by 362.47% to ¥97,248,116.25, mainly due to an increase in unexpired financial products at the end of the period[14] - Inventory decreased slightly to ¥814,421,864.28 from ¥831,939,255.95, indicating a decline of approximately 2.1%[23] Financing Activities - The company’s cash flow from financing activities increased by 32.13% to ¥321,236,158.09, reflecting higher borrowings received during the period[14] - The cash flow from financing activities included CNY 412,000,000.00 from borrowings, slightly down from CNY 443,247,871.10 in the previous year[36] Other Financial Metrics - The weighted average return on equity increased by 0.26 percentage points to 3.33%[7] - The company recorded investment income of ¥41,589.04, down from ¥1,145,124.67 in the previous period[26] - Other comprehensive income after tax for the current period was -¥621,890.36, compared to ¥495,709.12 in the previous period[27] - The company experienced a foreign exchange loss of CNY -3,466,496.05 during the quarter, compared to a gain of CNY 2,096,232.32 in the previous year[36]